These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6355310)

  • 21. Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses.
    Feldman RG; Ferrante A
    J Infect Dis; 1990 Oct; 162(4):883-7. PubMed ID: 2205651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative determination of antibodies to type III group B streptococcal polysaccharide.
    Guttormsen HK; Baker CJ; Edwards MS; Paoletti LC; Kasper DL
    J Infect Dis; 1996 Jan; 173(1):142-50. PubMed ID: 8537651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Type-specific antibody to type Ia, Ib, II and III group B Streptococcus in maternal and neonatal sera measured by ELISA].
    Sugiyama M; Kojima M; Hori Y; Simizu S; Sugiyama A; Ooe Y; Nishiyama Y
    Kansenshogaku Zasshi; 1990 Sep; 64(9):1232-8. PubMed ID: 2243195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of type-specific group B streptococcal antibody in pregnant women.
    Vogel LC; Boyer KM; Gadzala CA; Gotoff SP
    J Pediatr; 1980 Jun; 96(6):1047-51. PubMed ID: 6989972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunodeterminant specificity of human immunity to type III group B streptococcus.
    Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
    J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of IgM antibody to group B Streptococcus type III in human infants.
    Boyer KM; Klegerman ME; Gotoff SP
    J Infect Dis; 1992 Jun; 165(6):1049-55. PubMed ID: 1583322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.
    Bhushan R; Anthony BF; Frasch CE
    Infect Immun; 1998 Dec; 66(12):5848-53. PubMed ID: 9826364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin G and M composition of naturally occurring antibody to type III group B streptococci.
    Anthony BF; Concepcion NF; Wass CA; Heiner DC
    Infect Immun; 1984 Oct; 46(1):98-104. PubMed ID: 6384050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults.
    Kotloff KL; Fattom A; Basham L; Hawwari A; Harkonen S; Edelman R
    Vaccine; 1996 Apr; 14(5):446-50. PubMed ID: 8735558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous administration of human IgG to newborn infants: changes in serum antibody levels to GBS.
    Christensen KK; Christensen P; Seger RA
    Antibiot Chemother (1971); 1985; 35():247-53. PubMed ID: 3901901
    [No Abstract]   [Full Text] [Related]  

  • 31. Group B streptococcal vaccines.
    Baker CJ; Kasper DL
    Rev Infect Dis; 1985; 7(4):458-67. PubMed ID: 3898306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ELISA for type-specific group B streptococcal antibody and its clinical significance].
    Ooe Y; Nishiyama Y; Sugiyama A; Simizu S; Kunishima S; Itou T; Sugiyama M
    Kansenshogaku Zasshi; 1990 Oct; 64(10):1251-4. PubMed ID: 2258642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    Baker CJ; Kasper DL
    N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement.
    Anderson DC; Hughes BJ; Edwards MS; Buffone GJ; Baker CJ
    Pediatr Res; 1983 Jun; 17(6):496-502. PubMed ID: 6348689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.
    Baker CJ; Rench MA; Kasper DL
    N Engl J Med; 1990 Jun; 322(26):1857-60. PubMed ID: 2190087
    [No Abstract]   [Full Text] [Related]  

  • 36. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.
    Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF
    Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
    Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
    Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study.
    Lin FY; Philips JB; Azimi PH; Weisman LE; Clark P; Rhoads GG; Regan J; Concepcion NF; Frasch CE; Troendle J; Brenner RA; Gray BM; Bhushan R; Fitzgerald G; Moyer P; Clemens JD
    J Infect Dis; 2001 Oct; 184(8):1022-8. PubMed ID: 11574917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplacental passage of IgG antibody to group B streptococcus serotype Ia.
    Boyer KM; Papierniak CK; Gadzala CA; Parvin JD; Gotoff SP
    J Pediatr; 1984 Apr; 104(4):618-20. PubMed ID: 6368784
    [No Abstract]   [Full Text] [Related]  

  • 40. Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns.
    Suara RO; Adegbola RA; Mulholland EK; Greenwood BM; Baker CJ
    J Natl Med Assoc; 1998 Feb; 90(2):109-14. PubMed ID: 9510625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.